PHARMACOKINETIC INTERACTION BETWEEN TEGOPRAZAN AND METRONIDAZOLE/TETRACYCLINE/BISMUTH IN HEALTHY KOREAN SUBJECTS.

被引：0
|
作者：
Kim, M. [1 ]
Jeong, Y. [1 ]
Park, J. [1 ]
Moon, S. [1 ]
机构：
[1] Chonbuk Natl Univ Hosp, Jeonju Si, Jeollabuk Do, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-087
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [21] LACK OF A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND WARFARIN IN HEALTHY SUBJECTS.
    Plowchalk, D. R.
    Qiu, R.
    Terra, S. G.
    Corrigan, B.
    Fang, J.
    Fullerton, T.
    Liu, J.
    Byon, W.
    Mordenti, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [22] LACK OF A CLINICALLY MEANINGFUL PHARMACOKINETIC INTERACTION BETWEEN ERTUGLIFLOZIN AND GLIMEPIRIDE OR SIMVASTATIN IN HEALTHY SUBJECTS.
    Sahasrabudhe, V.
    Kumar, V.
    Matschke, K.
    Shi, H.
    Alvey, C.
    Liang, Y.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Zhou, S.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S46 - S47
  • [23] Evaluation of the comparative pharmacokinetic properties of a new orally disintegrating tablet of tegoprazan in healthy Korean subjects
    Lee, Jin A.
    Goak, In Sun
    Lee, Jiwon
    Kim, Bongtae
    Moon, Seol Ju
    Kwak, Yong-Geun
    Kim, Min-Gul
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (09) : 410 - 420
  • [24] Lack of pharmacokinetic interaction between retigabine and phenobarbital at steady-state in healthy subjects.
    Ferron, GM
    Patat, A
    Parks, V
    Rolan, P
    Troy, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P48 - P48
  • [25] EVALUATION OF THE POTENTIAL FOR STEADY-STATE PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND ASPIRIN IN HEALTHY SUBJECTS.
    Cho, H.
    Cho, D.
    Yeo, C.
    Bae, S.
    Shon, J.
    Park, S.
    Kim, E.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S95 - S95
  • [26] Pharmacokinetic and pharmacodynamic characteristics of ibandronate after a single intravenous infusion in healthy Korean subjects.
    Tae, Y. M.
    Lim, K. S.
    Kim, J. R.
    Kim, J. W.
    Kim, B. H.
    Jeon, J. Y.
    Yu, K. S.
    Shin, S. G.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S83 - S83
  • [27] PHARMACOKINETIC INTERACTION BETWEEN CLEVUDINE AND ADEFOVIR DIPIVOXIL AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY MALE SUBJECTS.
    Moon, S.
    Kim, S.
    Park, S.
    Kim, Y.
    Hwang, H.
    Yoon, S.
    Jang, I.
    Yu, K.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S23 - S23
  • [28] Population pharmacokinetic analysis of rimonabant in healthy subjects.
    Ferron, GM
    Grandison, M
    Lockwood, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P43 - P43
  • [29] A pharmacokinetic comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean subjects.
    Kim, U.
    Cho, S. H.
    Ghim, J. L.
    Choe, S. M.
    Jung, J. A.
    Lim, H. S.
    Bae, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S26 - S26
  • [30] PHARMACOKINETIC INTERACTION STUDY BETWEEN IVABRADINE WITH FLUOXETINE OR METRONIDAZOLE IN HEALTHY VOLUNTEERS
    Vlase, Laurian
    Popa, Adina
    Neag, Maria
    Muntean, Dana
    Leucuta, Sorin E.
    FARMACIA, 2010, 58 (04) : 471 - 477
12345